489 related articles for article (PubMed ID: 15809528)
1. Systemic inflammation, cachexia and prognosis in patients with cancer.
Deans C; Wigmore SJ
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):265-9. PubMed ID: 15809528
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia.
Fearon KC; Barber MD; Falconer JS; McMillan DC; Ross JA; Preston T
World J Surg; 1999 Jun; 23(6):584-8. PubMed ID: 10227928
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.
Winfield RD; Delano MJ; Pande K; Scumpia PO; Laface D; Moldawer LL
JPEN J Parenter Enteral Nutr; 2008; 32(6):651-5. PubMed ID: 18974247
[TBL] [Abstract][Full Text] [Related]
4. The origins of cachexia in acute and chronic inflammatory diseases.
Delano MJ; Moldawer LL
Nutr Clin Pract; 2006 Feb; 21(1):68-81. PubMed ID: 16439772
[TBL] [Abstract][Full Text] [Related]
5. Cachexia, survival and the acute phase response.
Stephens NA; Skipworth RJ; Fearon KC
Curr Opin Support Palliat Care; 2008 Dec; 2(4):267-74. PubMed ID: 19060563
[TBL] [Abstract][Full Text] [Related]
6. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory agents for the treatment of cachexia.
Chasen M; Bhargava R; Hirschman S
Curr Opin Support Palliat Care; 2014 Dec; 8(4):328-33. PubMed ID: 25111255
[TBL] [Abstract][Full Text] [Related]
8. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in the pathogenesis of cancer cachexia.
Argilés JM; Busquets S; López-Soriano FJ
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):401-6. PubMed ID: 12806213
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
11. Cachexia in cancer patients.
Tisdale MJ
Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
[No Abstract] [Full Text] [Related]
12. The impact of inflammation and acute phase activation in cancer cachexia.
Robinson TP; Hamidi T; Counts B; Guttridge DC; Ostrowski MC; Zimmers TA; Koniaris LG
Front Immunol; 2023; 14():1207746. PubMed ID: 38022578
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of cancer cachexia].
Lelbach A; Muzes G; Feheŕ J
Orv Hetil; 2004 Nov; 145(46):2329-34. PubMed ID: 16106904
[TBL] [Abstract][Full Text] [Related]
14. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammation, nutritional status and survival in patients with cancer.
McMillan DC
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):223-6. PubMed ID: 19318937
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue dysfunction in cancer cachexia.
Daas SI; Rizeq BR; Nasrallah GK
J Cell Physiol; 2018 Jan; 234(1):13-22. PubMed ID: 30078199
[TBL] [Abstract][Full Text] [Related]
18. Rethinking nutritional support for persons with cancer cachexia.
McCarthy DO
Biol Res Nurs; 2003 Jul; 5(1):3-17. PubMed ID: 12886666
[TBL] [Abstract][Full Text] [Related]
19. Update on emerging drugs for cancer cachexia.
Murphy KT; Lynch GS
Expert Opin Emerg Drugs; 2009 Dec; 14(4):619-32. PubMed ID: 19860537
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia.
DeJong CH; Busquets S; Moses AG; Schrauwen P; Ross JA; Argiles JM; Fearon KC
Oncol Rep; 2005 Jul; 14(1):257-63. PubMed ID: 15944798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]